Monday , 11 December 2017


These 4 Medical Marijuana Stocks Have Underperformed Their Peers Despite Healthy Gross Margins

Being able to sell products at a high margin is a good sign of efficiency. Doing so leavesmarijuana2 more cash to dedicate to other expenses and service debt obligations. Identifying undervalued companies with strong gross margins in the young marijuana industry is important, given the upcoming Canadian legalization of marijuana for recreational purposes in 2018. Today we have identified 4 Canadian marijuana stocks that have underperformed  their peers despite healthy gross margins.

This article is an edited ([ ]) and revised (…) version of the original (from SmallCapPower.com) to ensure a faster & easier read. It may be re-posted as long as it includes a hyperlink back to this revised version to avoid copyright infringement.

1. Canabo Medical Inc. (TSXV: CMM)

Canabo Medical Inc. is engaged in the provision of medical services and non-cannabinoid products for patients suffering from chronic pain and disabling illnesses.

The Company offers:

  1. 10 medical clinics across Canada operated by qualified health care cannabinoid educators who consult with patients to determine the proper treatment for their ailments using medical marijuana based on the medical documentation as prepared by the physician.

The company also provides independent medical marijuana evaluations for employers and insurers and independent medical marijuana scientific research.

  • Market Cap: $12.3 million
  • YTD Price Change: -64.3%
  • Gross Margin: 55.3%

2. Invictus MD Strategies Corp. (TSXV: IMH)

Invictus MD Strategies Corp. is a Canada-based company specializing in acquiring, funding and developing entities which are involved in the medicinal marijuana area.

The company focuses on:

  1. the production and distribution of medicinal marijuana through online stores;
  2. the sale of hydroponic equipment and fertilizers, as well as of accessories for cannabis intake:

The company also does research and testing and provides advisory services.

  • Market Cap: $46.1 million
  • YTD Price Change: -25.8%
  • Gross Margin: 44.6%

3. CanniMed Therapeutics Inc. (TSX: CMED)

CanniMed Therapeutics Inc. is a Canada-based plant biopharmaceutical company that:

  1. specializes in the production of pharmaceutical-grade cannabis;
  2. offers a range of pharmaceutical-grade cannabis products:
  3. provides a plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications.

The Company, through its subsidiary CanniMed Ltd, offers medical cannabis oils, dried medical cannabis, vaporizers, vaporizer parts and accessories. Its CanniMed Oils are made using only dried cannabis flowers.

  • Market Cap: $218.1 million
  • YTD Price Change: -10.5%
  • Gross Margin: 22.9%

4. Organigram Holdings Inc. (TSXV: OGI)

Organigram Holdings Inc., a Canada-based company, is a licensed medical marijuana producer as regulated by Health Canada under the Marijuana Medical Access Regulations (MMAR) of the Government of Canada.

  • Market Cap: $277.6 million
  • YTD Price Change: -7.6%
  • Gross Margin: 54.1%

Scroll to very bottom of page & add your comments on this article. We want to share what you have to say!

Related Articles from the munKNEE.com Vault:

1. These 5 Medical Marijuana Stocks Have the Greatest Upside Potential

Investing in marijuana-related stocks is a high-risk, high-reward game due to all the uncertainties surrounding the legalization of the drug. Companies that do succeed, however, have potential to bring large capital gains. That being said we have identified five Canadian marijuana stocks with the biggest upside potential, according to consensus analyst price targets.

2. Is One of These 5 Junior Marijuana Stocks Ripe For Acquisition?

The search is now on for the next junior marijuana stock that is ripe for acquisition. Will it be one of the 5 we’ve identified based upon their high revenue growth profiles?

3. Continued MAJOR Revenue Growth Expected From These 5 Marijuana Stocks in 2017

The following 5 marijuana stocks are expected to experience anywhere from 188% to 5,338.8% (yes, 5,338.8%!) in revenue growth during the upcoming year.

4. Wild Volatility: These Marijuana Stocks Provide Great Day-trading Opportunities

With intraday fluctuations of up to 80% – yes, 80% – the Canadian marijuana stocks on our list create significant day-trading opportunities for those so inclined.

5. Could These Marijuana Stocks Continue Feeling A Buzz From the Recent Election Results?

With operations in the U.S. or a high probability of expanding there, the Canadian marijuana stocks on list are likely going to continue to feel a buzz from the recent U.S. election.

6. Which Countries Smoke the Most Marijuana? Check Out the Map

A recent United Nations report on drug use reveals drug trends around the world, including which countries have the highest rates of cannabis use. Check out the map.

 munKNEE should be in everybody’s inbox and MONEY in everybody’s wallet!

If you want more articles like the one above sign up in the top right hand corner of this page and receive our FREE bi-weekly newsletter (see sample here).

 munKNEE.com – ” The internet’s most unique site for financial articles! Here’s why